ALCOX:EPA
NicOx SA
€ ०.३१
arrow_downward
-०.१६%(-०.०००५०) 1D
अक्टोबर १२, ११:०६:२१ GMT+२ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€ ०.३१
High
€ ०.३१
Low
€ ०.३१
Mkt. cap
३.०० करोड
Avg. vol.
१.६५ लाख
Volume
४५.२९ हजार
52-wk high
€ ०.५७
52-wk low
€ ०.२८
EPS
-€ ०.०३
Shares outstanding
९.७६ करोड
No. of employees
१०
Open
€ ०.३१
High
€ ०.३१
Low
€ ०.३१
Mkt. cap
३.०० करोड
Avg. vol.
१.६५ लाख
Volume
४५.२९ हजार
52-wk high
€ ०.५७
52-wk low
€ ०.२८
EPS
-€ ०.०३
Shares outstanding
९.७६ करोड
No. of employees
१०
News stories
From web sources and news partners
Sahi
·
१३ मिनेट पहिले
Black Box Shows Interest In Nasdaq Listed Aeries Technology Reporting $70 Million FY26 Revenue
Yahoo Finance
·
५५ मिनेट पहिले
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Bloomberg.com
·
११ घण्टा पहिले
Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees१०
Founded१९९६
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, फ्रान्स
Sector-
Websitenicox.com